MEDICLAS Study (Metabolic Effects of Different Classes of AntiretroviralS)

PHASE4UnknownINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

January 31, 2003

Study Completion Date

July 31, 2008

Conditions
HIV InfectionsHIV-Associated Lipodystrophy Syndrome
Interventions
DRUG

Lopinavir/ritonavir + zidovudine + lamivudine

DRUG

Lopinavir/ritonavir + nevirapine

Trial Locations (13)

Unknown

Helsinki University Central Hospital, Helsinki

Academic Medical Center, Amsterdam

Medisch Centrum Jan van Goyen, Amsterdam

Onze Lieve Vrouwe Gasthuis, location Oosterpark, Amsterdam

Onze Lieve Vrouwe Gasthuis, location Prinsengracht, Amsterdam

Slotervaart ziekenhuis, Amsterdam

VUMC Free University Medical Center, Amsterdam

Kennemer Gasthuis, location Elisabeth, Haarlem

Leids Universitair Medisch Centrum, Leiden

Erasmus Universitair Medisch Centrum, Rotterdam

Ziekenhuis Leyenburg, The Hague

Hospital Clinic, Barcelona

Royal Free Hospital, London

Sponsors
All Listed Sponsors
collaborator

Abbott

INDUSTRY

collaborator

Boehringer Ingelheim

INDUSTRY

lead

Amsterdam UMC, location VUmc

OTHER